During the past decade, Atlanta Women's Research Institute, Inc conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Women's Research Institute, Inc" #1 sponsor was "Repros Therapeutics Inc." with 4 trials, followed by "Abbott Research Group" with 1 trials sponsored, "Depomed" with 1 trials sponsored, "Graceway Pharmaceuticals, LLC" with 1 trials sponsored and "Jiangsu Kanion Pharmaceutical Co., Ltd" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Women's Research Institute, Inc" #1 collaborator was "Covance" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Women's Research Institute, Inc" are "Uterine Fibroids" (4 trials), "Genital Warts" (1 trials), "Hot Flashes" (1 trials), "Leiomyomas" (1 trials) and "Polycystic Ovary Syndrome (PCOS)" (1 trials). Many other conditions were trialed in "Atlanta Women's Research Institute, Inc" in a lesser frequency.

Most popular intervention types in "Atlanta Women's Research Institute, Inc" are "Drug" (10 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "2.5% imiquimod cream" (1 trials), "3.75% imiquimod cream" (1 trials), "Gabapentin Extended-Release (G-ER) 1200 mg" (1 trials) and "Gabapentin Extended-Release (G-ER) 1800 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Women's Research Institute, Inc" are 10 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Women's Research Institute, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Atlanta Women's Research Institute, Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Women's Research Institute, Inc, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".